Results 131 to 140 of about 2,254 (197)

Malignant glaucoma with variable outcomes after irido-zonulo-hyaloid-vitrectomy-bilateral involvement: a case report. [PDF]

J Med Case Rep
Li N, Dang Y, Lei F.
europepmc   +1 more source

Varicella zoster virus acute retinal necrosis miming papillitis: a case report. [PDF]

J Med Case Rep
Sasso P, Gambini G, Maceroni M, D'Ambrosi F, Romano L, Caputo CG, Tamburrini E, Rizzo S, Minnella AM.   +8 more
europepmc   +1 more source

Drug induced hyperpigmentation: systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Alharithy R, Alotaibi K, Bin Salamah R, Altamimi R, Alqntash N, Alsarhan R, Khosyfan L, Alrowais S.   +7 more
europepmc   +1 more source

Efficacy and Safety of Carbonic Anhydrase Inhibitors in the Management of Central Serous Chorioretinopathy. [PDF]

J Vitreoretin Dis
Abu Serhan H, Ashraf S, Saeed H, Safiullah M, Ul Haq MZ, Shaukat A, Ansari MA, Shah MSU, Ahmed A.   +8 more
europepmc   +1 more source

Pharmacological management of nystagmus: An in-depth review for clinical practice.

Oman J Ophthalmol
Asadigandomani H, Kazemian P, Khorrami-Nejad M, Al Kalbani HS, Masoomian B.   +4 more
europepmc   +1 more source

Efficacy Analysis of Capsular Tension Ring Ciliary Sulcus Suture Fixation for Lens Subluxation

Lan X, Bai H, Teng Y, Sun J, Wu X.
europepmc   +1 more source

The Efficacy, Safety, and Satisfaction Associated with Switching from Brinzolamide or Brimonidine to Brinzolamide/Brimonidine in Open-Angle Glaucoma Patients

Journal of Personalized Medicine, 2022
We evaluated switching from brinzolamide 1% or brimonidine 0.1% to a fixed-combination of brinzolamide 1% and brimonidine 0.1%, and then determined the efficacy, safety, and satisfaction associated with these changes in glaucoma patients.
Hiromitsu Onoe, Kazuyuki Hirooka, Yoshiaki Kiuchi   +2 more
exaly   +2 more sources

The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients

Journal of Clinical Medicine, 2021
We evaluated glaucoma patients for the efficacy, safety and satisfaction associated with switching from brinzolamide 1% and brimonidine 0.1% to a fixed combination of brinzolamide 1% and brimonidine 0.1%. A total of 22 glaucoma patients were enrolled and
Hiromitsu Onoe, Kazuyuki Hirooka, Hideaki Okumichi   +2 more
exaly   +2 more sources

Process for the preparation of brinzolamide

, 2009
The present invention relates to a process for the preparation of Brinzolamide, or 2H-thieno[3,2-e]-1, 2-thiazin-6-sulfonamide, 4-(ethyl amino)-3, 4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide,(4R)- via intermediates 2,3-dihydro-4H-thieno[3,2-e]-1, 2-thiazin-4-ones, 1,1-dioxide.
DE LUCCHI, Ottorino, CASTELLIN A.
openaire   +2 more sources

Direct and crossover effects of brinzolamide, betaxolol, and latanoprost on choroidal thickness

Cutaneous and Ocular Toxicology, 2019
Aslan, Mehmet Gokhan/0000-0002-3250-1606; Findik, Huseyin/0000-0001-7343-8757Purpose: To investigate the acute effects of brinzolamide, betaxolol, and latanoprost (drugs commonly used in the medical management of glaucoma) on choroidal thickness using ...
Murat Okutucu, Huseyin Fındık, Mehmet Gokhan Aslan   +2 more
exaly   +2 more sources